LENZ Therapeutics, Inc. (GRPH) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LENZ Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $947 K, a 567% increase year-over-year.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $11.4 M, a 10.1% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6 M, a 21.9% decline from 2022.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5 M, a 71.9% increase from 2021.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.87 M, a 4347% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.4 M $947 K +$805 K +567% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $10.6 M $5.43 M +$1.8 M +49.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $8.77 M $2.16 M -$1.05 M -32.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $9.82 M $2.85 M -$515 K -15.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $10.3 M $142 K -$3.2 M -95.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $13.5 M $3.62 M +$1.18 M +48.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $12.4 M $3.21 M +$836 K +35.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.5 M $3.36 M +$1.34 M +66.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $10.2 M $3.34 M +$2.31 M +224% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.87 M $2.45 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $2.37 M +$2.34 M +6494% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.02 M +$2.02 M +201700% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.03 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $36 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1 K* Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.